[Behavioral and neuopharmacological effects of flupentixol].
D000777:Anesthetics; D000818:Animals; D000932:Antiemetics / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D002375:Catalepsy; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D004357:Drug Synergism; D004569:Electroencephalography; D000431:Ethanol / Q000494:pharmacology; D006801:Humans; D008297:Male; D008635:Mescaline / Q000037:antagonists & inhibitors; D008694:Methamphetamine / Q000037:antagonists & inhibitors; D009020:Morphine / Q000037:antagonists & inhibitors; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D010546:Perphenazine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D012640:Seizures; D012890:Sleep / Q000187:drug effects; D013116:Spinal Cord / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014966:Xanthenes / Q000494:pharmacology*
D000777:Anesthetics; D000932:Antiemetics; D009125:Muscle Relaxants, Central; D010879:Piperazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D000431:Ethanol; D008694:Methamphetamine; D009020:Morphine; D012110:Reserpine; D010546:Perphenazine; D008635:Mescaline; D002746:Chlorpromazine